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Introduction 
This is the first edition of guidance on infection prevention 
and control (IPC) strategies for use when infection with a 
novel coronavirus (2019-nCoV) is suspected. It has been 
adapted from WHO’s Infection prevention and control during 
health care for probable or confirmed cases of Middle East 
respiratory syndrome coronavirus (MERS-CoV) infection,1 
based on current knowledge of the situation in China and 
other countries where cases were identified and experiences 
with severe acute respiratory syndrome (SARS)-CoV and 
MERS-CoV.2  
WHO will update these recommendations as new information 
becomes available.   
This guidance is intended for healthcare workers (HCWs), 
healthcare managers and IPC teams at the facility level but it 
is also relevant for the national and district/provincial level. 
Full guidelines are available from WHO.2 
 
Principles of IPC strategies associated with 
health care for suspected nCoV infection 
To achieve the highest level of effectiveness in the response 
to an 2019-nCoV outbreak using the strategies and practices 
recommended in this document, an IPC programme with a 
dedicated and trained team or at least an IPC focal point 
should be in place and supported by the national and facility 
senior management.3 In countries where IPC is limited or 
inexistent, it is critical to start by ensuring that at least 
minimum requirements for IPC are in place as soon as 
possible, both at the national and facility level, and to 
gradually progress to the full achievement of all requirements 
of the IPC core components according to local priority plans.4 
IPC strategies to prevent or limit transmission in healthcare 
settings include the following:  
1. ensuring triage, early recognition, and source 
control (isolating patients with suspected nCoV 
infection); 
2. applying standard precautions for all patients;  
3. implementing empiric additional precautions 
(droplet and contact and, whenever applicable, 
airborne precautions) for suspected cases of nCoV 
infection; 
4. implementing administrative controls; 
5. using environmental and engineering controls. 
 
1. Ensuring triage, early recognition, and source 
control 
Clinical triage includes a system for assessing all patients at 
admission allowing early recognition of possible 2019-nCoV 
infection and immediate isolation of patients with suspected 
nCoV infection in an area separate from other patients (source 
control). To facilitate the early identification of cases of 
suspected nCoV infection, healthcare facilities should:  
• encourage HCWs to have a high level of clinical 
suspicion;  
• establish a well-equipped triage station at the 
entrance of health care facility, supported by trained 
staff; 
• institute the use of screening questionnaires 
according to the updated case definition 
(https://www.who.int/publications-detail/global-
surveillance-for-human-infection-with-novel-
coronavirus-(2019-ncov) and  
• post signs in public areas reminding symptomatic 
patients to alert HCWs.  
The promotion of hand hygiene and respiratory hygiene are 
essential preventive measures. 
 
2. Applying standard precautions for all patients 
Standard precautions include hand and respiratory hygiene, 
the use of appropriate personal protective equipment (PPE) 
according to risk assessment, injection safety practices, safe 
waste management, proper linens, environmental cleaning 
and sterilization of patient-care equipment.  
Ensure that the following respiratory hygiene measures are 
used: 
• ensure that all patients cover their nose and mouth 
with a tissue or elbow when coughing or sneezing; 
• offer a medical mask to patients with suspected 
2019-nCoV infection while they are in 
waiting/public areas or in cohorting rooms;  
• perform hand hygiene after contact with respiratory 
secretions. 
HCWs should apply the WHO’s My 5 Moments for Hand 
Hygiene approach before touching a patient, before any clean 
or aseptic procedure is performed, after exposure to body 
fluid, after touching a patient, and after touching a patient’s 
surroundings.5 
• hand hygiene includes either cleansing hands with an 
alcohol-based hand rub (ABHR) or with soap and water; 
• alcohol-based hand rubs are preferred if hands are not 
visibly soiled; 
• wash hands with soap and water when they are visibly 
soiled. 
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The rational, correct, and consistent use of PPE also helps to 
reduce the spread of pathogens. The use of PPE effectiveness 
strongly depends on adequate and regular supplies, adequate 
staff training, appropriate hand hygiene and specifically 
appropriate human behaviour. 2,5,6 
 
It is important to ensure that environmental cleaning and 
disinfection procedures are followed consistently and 
correctly. Thoroughly cleaning environmental surfaces with 
water and detergent and applying commonly used hospital-
level disinfectants (such as sodium hypochlorite) are effective 
and sufficient procedures.7 Medical devices and equipment, 
laundry, food service utensils and medical waste should be 
managed in accordance with safe routine procedures.2,8  
 
3. Implementing empiric additional precautions  
3.1 Contact and droplet precautions  
• in addition to using standard precautions, all 
individuals, including family members, visitors and 
HCWs, should use contact and droplet precautions 
before entering the room where suspected or 
confirmed nCoV patients are admitted; 
• patients should be placed in adequately ventilated 
single rooms. For general ward rooms with natural 
ventilation, adequate ventilation is considered to be 
60 L/s per patient;9  
• when single rooms are not available, patients 
suspected of being infected with nCoV should be 
grouped together; 
• all patients’ beds should be placed at least 1 m apart 
regardless of whether they are suspected to have 
nCov infection; 
• where possible, a team of HCWs should be 
designated to care exclusively for suspected or 
confirmed cases to reduce the risk of transmission; 
• HCWs should use a medical mask a  (for 
specifications, please see references 2); 
• HCWs should wear eye protection (googles) or 
facial protection (face shield) to avoid 
contamination of mucous membranes; 
• HCWs should wear a clean, non-sterile, long-
sleeved gown;  
• HCWs should also use gloves; 
• the use of boots, coverall and apron is not required 
during routine care;  
• after patient care, appropriate doffing and disposal 
of all PPE's and hand hygiene should be carried 
out.5,6 Also, a new set of PPE's is needed, when care 
is given to a different patient; 
• equipment should be either single-use and 
disposable or dedicated equipment (e.g., 
stethoscopes, blood pressure cuffs and 
thermometers). If equipment needs to be shared 
among patients, clean and disinfect it between use 
for each individual patient (e.g., by using ethyl 
alcohol 70%);8 
                                                          
a Medical masks are surgical or procedure masks that are flat or pleated  
   (some are like cups); they are affixed to the head with straps2 
• HCWs should refrain from touching eyes, nose or 
mouth with potentially contaminated gloved or bare 
hands; 
• avoid moving and transporting patients out of their 
room or area unless medically necessary. Use 
designated portable X-ray equipment and/or other 
designated diagnostic equipment. If transport is 
required, use predetermined transport routes to 
minimize exposure for staff, other patients and 
visitors, and have the patient using a medical mask; 
• ensure that HCWs who are transporting patients 
perform hand hygiene and wear appropriate PPE as 
described in this section;  
• notify the area receiving the patient of any necessary 
precautions as early as possible before the patient’s 
arrival; 
• routinely clean and disinfect surfaces which the 
patient is in contact; 
• limit the number of HCWs, family members and 
visitors who are in contact with a suspected and 
confirmed 2019-nCoV patient; 
• maintain a record of all persons entering the 
patient’s room, including all staff and visitors. 
 
3.2 Airborne precautions for aerosol-generating 
procedures  
Some aerosol-generating procedures have been 
associated with an increased risk of transmission of 
coronaviruses (SARS-CoV and MERS-CoV), such 
as tracheal intubation, non-invasive ventilation, 
tracheotomy, cardiopulmonary resuscitation, 
manual ventilation before intubation, and 
bronchoscopy.10,11  
Ensure that HCWs performing aerosol-generating 
procedures: 
• perform procedures in an adequately ventilated 
room – that is, natural ventilation with air flow 
of at least 160 L/s per patient or in negative 
pressure rooms with at least 12 air changes per 
hour and controlled direction of air flow when 
using mechanical ventilation;9 
• use a particulate respirator at least as protective 
as a US National Institute for Occupational 
Safety and Health (NIOSH)-certified N95, 
European Union (EU) standard FFP2, or 
equivalent.2,12 When HCWs put on a disposable 
particulate respirator, they must always perform 
the seal check.12 Note that if the wearer has 
facial hair (i.e., a beard) it may prevent a proper 
respirator fit;12 
• use eye protection (i.e., goggles or a face shield); 
• wear a clean, non-sterile, long-sleeved gown 
and gloves. If gowns are not fluid resistant, 
HCWs should use a waterproof apron for 
procedures expected to have high volumes of 
fluid that might penetrate the gown;2 
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• limit the number of persons present in the room 
to the absolute minimum required for the 
patient’s care and support. 
 
4. Implementing administrative controls   
Administrative controls2 and policies for  the prevention and 
control of transmission of 2019-nCoV infections within the 
healthcare setting include, but may not be limited to: 
establishing sustainable IPC infrastructures and activities; 
educating patients’ caregivers; developing policies on the 
early recognition of acute respiratory infection potentially 
caused by 2019-nCoV; ensuring access to prompt laboratory 
testing for identification of the etiologic agent; preventing 
overcrowding, especially in the emergency department; 
providing dedicated waiting areas for symptomatic patients; 
appropriately isolating hospitalized patients; ensuring 
adequate supplies of PPE; ensure the adherence of IPC 
policies and procedures for all facets of  health care.  
4.1. Administrative measures related to healthcare 
workers 
• provision of adequate training for HCWs; 
• ensuring an adequate patient-to-staff ratio;  
• establishing a surveillance process for acute 
respiratory infections potentially caused by nCoV 
among HCWs;  
• ensuring that HCWs and the public understand the 
importance of promptly seeking medical care; 
• monitoring HCW compliance with standard 
precautions and providing mechanisms for 
improvement as needed.  
 
5. Using environmental and engineering controls 
These controls address the basic infrastructure of the health 
care facility.13 These controls aim to ensure there is adequate 
ventilation9 in all areas in the healthcare facility, as well as 
adequate environmental cleaning.  
Additionally, spatial separation of at least 1 meter should be 
maintained between all patients. Both spatial separation and 
adequate ventilation can help reduce the spread of many 
pathogens in the healthcare setting.14 
Ensure that cleaning and disinfection procedures are followed 
consistently and correctly.8 Cleaning environmental surfaces 
with water and detergent and applying commonly used 
hospital disinfectants (such as sodium hypochlorite) is an 
effective and sufficient procedure.7 Manage laundry, food 
service utensils and medical waste in accordance with safe 
routine procedures.  
 
Duration of contact and droplet precautions for 
patients with nCoV infection 
Standard precautions should be applied at all times. 
Additional contact and droplet precautions should continue 
until the patient is asymptomatic. More comprehensive 
information about the mode of 2019-nCoV infection 
transmission is required to define the duration of additional 
precautions.  
 
 
Collecting and handling laboratory specimens 
from patients with suspected 2019-nCoV 
infection 
All specimens collected for laboratory investigations should 
be regarded as potentially infectious. HCWs who collect, 
handle or transport any clinical specimens should adhere 
rigorously to the following standard precaution measures and 
biosafety practices to minimize the possibility of exposure to 
pathogens.15,16,17 
• ensure that HCWs who collect specimens use 
appropriate PPE (i.e., eye protection, a medical mask, a 
long-sleeved gown, gloves). If the specimen is collected 
with an aerosol-generating procedure, personnel should 
wear a particulate respirator at least as protective as a 
NIOSH-certified N95, an EU standard FFP2, or the 
equivalent; 
• ensure that all personnel who transport specimens are 
trained in safe handling practices and spill 
decontamination procedures;7 
• place specimens for transport in leak-proof specimen 
bags (i.e., secondary containers) that have a separate 
sealable pocket for the specimen (i.e., a plastic biohazard 
specimen bag), with the patient’s label on the specimen 
container (i.e., the primary container), and a clearly 
written laboratory request form; 
• ensure that laboratories in health care facilities adhere to 
appropriate biosafety practices and transport 
requirements, according to the type of organism being 
handled; 
• deliver all specimens by hand whenever possible. DO 
NOT use pneumatic-tube systems to transport specimens; 
• document clearly each patient’s full name, date of birth 
and  suspected nCoV of potential concern on the 
laboratory request form. Notify the laboratory as soon as 
possible that the specimen is being transported. 
 
Recommendation for outpatient care 
The basic principles of IPC and standard precautions should 
be applied in all health care facilities, including outpatient 
care and primary care. For 2019-nCoV infection, the 
following measures should be adopted: 
• triage and early recognition; 
• emphasis on hand hygiene, respiratory hygiene and 
medical masks to be used by patients with respiratory 
symptoms; 
• appropriate use of contact and droplet precautions for all 
suspected cases; 
• prioritization of care of symptomatic patients; 
• when symptomatic patients are required to wait, ensure 
they have a separate waiting area; 
• educate patients and families about the early recognition 
of symptoms, basic precautions to be used and which 
health care facility they should refer to. 
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